Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)

Title
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
Authors
Keywords
-
Journal
INVESTIGATIONAL NEW DRUGS
Volume 28, Issue 3, Pages 260-267
Publisher
Springer Nature
Online
2009-03-23
DOI
10.1007/s10637-009-9243-7

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started